| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SYN.21840 |
| P698 | PubMed publication ID | 26178667 |
| P50 | author | Diego Fernández-Fernández | Q40250041 |
| P2093 | author name string | Holger Rosenbrock | |
| Katja S Kroker | |||
| P2860 | cites work | The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging | Q46579486 |
| Effects of Cd(2+) on AMPA receptor-mediated synaptic transmission in rat hippocampal CA1 area | Q46772642 | ||
| Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease | Q46796290 | ||
| mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain | Q47378008 | ||
| Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801. | Q47961152 | ||
| Paired-pulse ratio of synaptically induced transporter currents at hippocampal CA1 synapses is not related to release probability | Q48177619 | ||
| Acute low-dose melamine affects hippocampal synaptic plasticity and behavior in rats | Q48399222 | ||
| Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action | Q48433430 | ||
| Electrophysiological identification of medial and lateral perforant path inputs to the dentate gyrus. | Q48439089 | ||
| Modulation of synaptic efficacy in field CA1 of the rat hippocampus by forskolin | Q48509942 | ||
| Coexpressed auxiliary subunits exhibit distinct modulatory profiles on AMPA receptor function | Q48634825 | ||
| Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo | Q48663240 | ||
| Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP. | Q48713138 | ||
| Baclofen and Adenosine Inhibition of Synaptic Transmission at CA3-CA1 Synapses Display Differential Sensitivity to K+ Channel Blockade | Q48922764 | ||
| Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. | Q49115644 | ||
| PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition | Q50669500 | ||
| A comparison of paired-pulse facilitation of AMPA and NMDA receptor-mediated excitatory postsynaptic currents in the hippocampus | Q57919729 | ||
| Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase | Q24324433 | ||
| The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding | Q24538689 | ||
| Phosphodiesterases in neurodegenerative disorders | Q27026359 | ||
| Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase | Q28117232 | ||
| Phosphodiesterases in the CNS: targets for drug development | Q28255355 | ||
| Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use | Q28263273 | ||
| Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance | Q28294344 | ||
| Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes | Q28511192 | ||
| A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2 | Q28572706 | ||
| Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling | Q29615163 | ||
| The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive funct | Q34187988 | ||
| The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents | Q34803405 | ||
| The distribution of phosphodiesterase 2A in the rat brain. | Q35538783 | ||
| Glutamate-induced AMPA receptor desensitization increases their mobility and modulates short-term plasticity through unbinding from Stargazin | Q35557654 | ||
| Natriuretic peptides block synaptic transmission by activating phosphodiesterase 2A and reducing presynaptic PKA activity. | Q36378347 | ||
| Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. | Q37245947 | ||
| The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons. | Q37317832 | ||
| Adenosine receptors and the central nervous system. | Q37565205 | ||
| Short-Term Presynaptic Plasticity | Q38023125 | ||
| Adenosine: setting the stage for plasticity | Q38075271 | ||
| The role of phosphodiesterases in hippocampal synaptic plasticity. | Q38077346 | ||
| PDE2 inhibition: potential for the treatment of cognitive disorders | Q38159848 | ||
| Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview. | Q38243486 | ||
| Polyamine-dependent facilitation of postsynaptic AMPA receptors counteracts paired-pulse depression | Q39435627 | ||
| Molecular profiling of synaptic vesicle docking sites reveals novel proteins but few differences between glutamatergic and GABAergic synapses | Q39755046 | ||
| A multi-slice recording system for stable late phase hippocampal long-term potentiation experiments | Q39959271 | ||
| Multimodal gain control at the hippocampal Schaffer collateral-CA1 synapse | Q40243309 | ||
| Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues | Q43056626 | ||
| Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons | Q43154334 | ||
| Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis | Q45158715 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 484-496 | |
| P577 | publication date | 2015-07-14 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus | |
| P478 | volume | 69 |
| Q90198060 | Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development |
| Q48590250 | Dorsal root ganglion axon bifurcation tolerates increased cyclic GMP levels: the role of phosphodiesterase 2A and scavenger receptor Npr3. |
| Q92350938 | Dysregulation of Neuronal Genes by Fetal-Neonatal Iron Deficiency Anemia Is Associated with Altered DNA Methylation in the Rat Hippocampus |
| Q88398634 | HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein |
| Q87937120 | Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A |
| Q47569499 | Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets |
| Q26746978 | Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012 |
| Q40103310 | Overexpression of Protein Kinase Mζ in the Hippocampus Enhances Long-Term Potentiation and Long-Term Contextual But Not Cued Fear Memory in Rats. |
| Q47611419 | PDE Inhibitors for the Treatment of Schizophrenia |
| Q46299650 | Role of PDE9 in Cognition |
Search more.